Provider review
Remedy Meds tirzepatide review
Remedy Meds tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
Updated 2026-09-18 · Public-source editorial · See dated evidence below
Remedy Meds charges $399 a month for compounded tirzepatide and does not change that figure no matter how high your dose goes.
Flat pricing at every dose is genuinely valuable and too rare in this market. The difficulty is the level it is flat at: $399 is roughly double the flat-rate leaders for the same class of compounded medication. The first month is discounted to $279, then it renews at $399.
Recorded costs and what to confirm
| Comparison step | Tirzepatide at Remedy Meds |
|---|---|
| Earlier figures | Dated cost record |
| Treatment | Name the product, route, prescribed amount and supply period |
| First payment | Itemize medicine, care, tests, supplies and delivery |
| Renewal | Give the next charge, its date and the supply it covers |
| Change or exit | Explain remaining charges and any refund before payment |
The $279 is a first-month rate; it renews at $399. Flat across every dose, which benefits anyone titrating high.
About $4,788 a year at the renewal rate. Coreage Rx month-to-month is roughly $2,388 and Trimi about $1,500 on the annual plan, for medication of the same category.
How Remedy Meds works
Compounded GLP-1 programme with two flat monthly prices that do not change with dose, medication included in the monthly fee.
Medication is included in the monthly fee rather than billed separately, and unlimited clinician access, check-ins and dose adjustments come with it. Branded Zepbound is available through the same programme at around $1,399 a month.
The earlier source record
- Compounded semaglutide priced at $299/month flat, regardless of dose.
- Compounded tirzepatide priced at $399/month flat, regardless of dose.
- First month of tirzepatide discounted to $279, then $399/month.
- Medication is included in the monthly fee rather than billed separately.
- Unlimited clinician access, check-ins and dose adjustments included.
- Branded Zepbound offered at around $1,399/month.
The underlying record is dated 2026-09-18. Its amounts, plan details and service descriptions are historical. Confirm the exact product, billing interval, included services and renewal terms before using a figure as a budget.
Where it is strong
- Genuinely flat pricing — the dose can go to the top of the ladder without the bill moving.
- Unlimited clinician access is included rather than sold as an upgrade.
- Medication is inside the monthly fee, so there is no second bill.
Where it falls short
- Expensive relative to the flat-rate leaders for the same class of medication.
- The $279 first month steps up to $399 on renewal.
The thing most people miss
The $279 introductory tirzepatide month renews at $399. Budget from the renewal figure.
How it scored
The historical rubric gives Remedy Meds 3.5 out of 5. Display position 16 of 23 also reflects commercial placements; it is not a clinical quality rank. These scores have not been independently revalidated. See how we rate.
| What we weigh | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 2.9 / 5 |
| Price honesty | 20% | 4 / 5 |
| Clinical support | 20% | 4 / 5 |
| Pharmacy sourcing | 15% | 3.5 / 5 |
| Cancelling | 15% | 3.4 / 5 |
Who it suits
Reasonable for someone who values unlimited clinician contact and a price that never moves, and who is not optimising hard on cost. Difficult to justify against the flat-rate leaders otherwise.
Our verdict
The right structure at the wrong number. If flat dose pricing is what you want, several programmes here offer it for half as much.
How it compares on tirzepatide
| # | Provider | Cost record | Compare a new quote | Historical score |
|---|---|---|---|---|
| 1 | Coreage Rx Featured | Dated cost record | Product, supply, fees and renewal | 4.5 |
| 2 | SuperHealthy Rx | Dated cost record | Product, supply, fees and renewal | Not scored |
| 3 | Likeness Rx | Dated cost record | Product, supply, fees and renewal | Not scored |
| 4 | Trimi | Dated cost record | Product, supply, fees and renewal | 4.6 |
| 5 | PlexusDx | Dated cost record | Product, supply, fees and renewal | 4.4 |
| 6 | Ozari Health | Dated cost record | Product, supply, fees and renewal | 4.4 |
| 7 | Fifty 410 | Dated cost record | Product, supply, fees and renewal | 4.2 |
| 8 | Ivím Health | Dated cost record | Product, supply, fees and renewal | 4 |
| 9 | Mochi Health | Dated cost record | Product, supply, fees and renewal | 3.6 |
| 10 | Coby Health | Dated cost record | Product, supply, fees and renewal | 3.6 |
| 11 | Hims & Hers | Dated cost record | Product, supply, fees and renewal | 3.5 |
| 12 | Ro | Dated cost record | Product, supply, fees and renewal | 3.5 |
The full reasoning behind this order is in our best tirzepatide providers guide.
Read next
- Coreage Rx tirzepatide review
Coreage Rx tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
- Likeness Rx semaglutide review
Likeness Rx semaglutide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
- Trimi tirzepatide review
Trimi tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
- The best tirzepatide providers in 2026
23 historical provider records, with cost-component questions, clinical evidence limits and commercial placements explained.
- Remedy Meds Semaglutide Review: Cost, Refills and Cancellation
What Remedy Meds publishes about subscription cost, medication supply, refills, cancellation and review limitations.
- How to Compare GLP-1 Costs: Fees, Refills and Renewal
Separate medication, care fees, supply duration, prepayment and renewal when comparing a GLP-1 quote.
Coreage Rx pays us a commission on sign-ups through our links. Commercial placements affect display order; the tables are not clinical recommendations. How we rate · Disclosure
